Increased κ-opioid receptor expression and function during chronic visceral hypersensitivity

Gut

Volumn 63, Issue 7, 2014, Pages 1199-1200

  Hughes, Patrick A ^a,b   Castro, Joel ^a,b   Harrington, Andrea M ^a,b   Isaacs, Nicole ^a   Moretta, Melissa ^a   Hicks, Gareth A ^c   Urso, David M ^c   Brierley, Stuart M ^a,b,d  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

^c Tioga Pharmaceuticals Inc   (United States)

^d UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ASIMADOLINE; KAPPA OPIATE RECEPTOR; MESSENGER RNA;

ABDOMINAL PAIN; ANIMAL EXPERIMENT; ANIMAL MODEL; COLITIS; CONTROLLED STUDY; DOSE RESPONSE; INTESTINE INNERVATION; MOUSE; NONHUMAN; NOTE; PAIN RECEPTOR; PRIORITY JOURNAL; SPINAL GANGLION; UPREGULATION;

ABDOMINAL PAIN; IRRITABLE BOWEL SYNDROME; PHARMACOTHERAPY;

ANIMALS; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; NEUROIMMUNOMODULATION;

EID: 84902297192     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-306240     Document Type: Note

References (10)

1. Hughes PA, Harrington AM, Castro J, et al. Sensory neuro-immune interactions differ between Irritable Bowel Syndrome subtypes. Gut 2013;62:1456-65.
2. Verma-Gandhu M, Bercik P, Motomura Y, et al. CD4 + T-cell modulation of visceral nociception in mice. Gastroenterology 2006;130:1721-8. (Pubitemid 43668870)
3. Delgado-Aros S, Chial HJ, Camilleri M, et al. Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans. Am J Physiol Gastrointest Liver Physiol 2003;284:G558-66. (Pubitemid 36343204)
4. Delvaux M, Beck A, Jacob J, et al. Effect of asimadoline, a kappa opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2004;20:237-46. (Pubitemid 38998223)
5. Mangel AW, Hicks GA. Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review. Clin Exp Gastroenterol 2012;5:1-10.
6. Hughes PA, Brierley SM, Martin CM, et al. Post-inflammatory colonic afferent sensitisation: different subtypes, different pathways and different time courses. Gut 2009;58:1333-41.
7. Berg KA, Rowan MP, Sanchez TA, et al. Regulation of kappa-opioid receptor signaling in peripheral sensory neurons in vitro and in vivo. J Pharmacol ExpTher 2011;338:92-9.
8. Bi J, Tsai NP, Lin YP, et al. Axonal mRNA transport and localized translational regulation of kappa-opioid receptor in primary neurons of dorsal root ganglia. Proc Natl Acad Sci USA 2006;103:19919-24. (Pubitemid 46037531)
9. Sengupta JN, Snider A, Su X, et al. Effects of kappa opioids in the inflamed rat colon. Pain 1999;79:175-85. (Pubitemid 29076752)
10. Hughes PA, Zola H, Penttila IA, et al. Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms? Am J Gastroenterol 2013;108:1066-74.